Biolab Equipt Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-06-2024
- Paid Up Capital ₹ 0.50 M
as on 30-06-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.39 M
as on 30-06-2024
- Revenue 211.58%
(FY 2021)
- Profit 125.12%
(FY 2021)
- Ebitda 31.33%
(FY 2021)
- Net Worth 5.62%
(FY 2021)
- Total Assets -22.41%
(FY 2021)
About Biolab Equipt
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.39 M.
Rajib Savapandit and Kumkum Baruah serve as directors at the Company.
- CIN/LLPIN
U33111WB2009PTC139237
- Company No.
139237
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
North 24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Biolab Equipt Private Limited offer?
Biolab Equipt Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services.
Who are the key members and board of directors at Biolab Equipt?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajib Savapandit  | Director | 06-Nov-2009 | Current |
| Kumkum Baruah | Director | 06-Nov-2009 | Current |
Financial Performance of Biolab Equipt.
Biolab Equipt Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 211.58% increase. The company also saw a substantial improvement in profitability, with a 125.12% increase in profit. The company's net worth moved up by a moderate rise of 5.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biolab Equipt?
In 2020, Biolab Equipt had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jorhat Bonded Warehouse Private LimitedActive 22 years 23 daysRajib Savapandit and Kumkum Baruah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Sep 2022 | ₹0.13 M | Open |
Others Creation Date: 10 Aug 2022 | ₹0.26 M | Open |
How Many Employees Work at Biolab Equipt?
Unlock and access historical data on people associated with Biolab Equipt, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biolab Equipt, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biolab Equipt's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
